Short Interest in Zhengye Biotechnology Holding Limited (NASDAQ:ZYBT) Declines By 36.7%

Zhengye Biotechnology Holding Limited (NASDAQ:ZYBT) was the target of a significant drop in short interest during the month of March. As of March 13th, there was short interest totaling 12,913 shares, a drop of 36.7% from the February 26th total of 20,412 shares. Based on an average trading volume of 8,690 shares, the short-interest ratio is currently 1.5 days. Approximately 0.0% of the shares of the stock are short sold.

Hedge Funds Weigh In On Zhengye Biotechnology

A number of large investors have recently bought and sold shares of the stock. Citadel Advisors LLC purchased a new stake in shares of Zhengye Biotechnology during the third quarter valued at approximately $31,000. Millennium Management LLC purchased a new position in shares of Zhengye Biotechnology in the third quarter worth $38,000. WINTON GROUP Ltd purchased a new position in shares of Zhengye Biotechnology in the third quarter worth $56,000. Geode Capital Management LLC bought a new stake in Zhengye Biotechnology during the 2nd quarter valued at $174,000. Finally, Invesco Ltd. bought a new stake in Zhengye Biotechnology during the 2nd quarter valued at $220,000.

Zhengye Biotechnology Price Performance

Shares of NASDAQ:ZYBT opened at $0.85 on Friday. The stock’s 50-day moving average price is $0.90 and its 200-day moving average price is $2.29. The company has a quick ratio of 1.10, a current ratio of 1.49 and a debt-to-equity ratio of 0.01. Zhengye Biotechnology has a 12-month low of $0.68 and a 12-month high of $14.30.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings restated a “sell (d-)” rating on shares of Zhengye Biotechnology in a report on Friday, January 9th. One analyst has rated the stock with a Sell rating, Based on data from MarketBeat, Zhengye Biotechnology has a consensus rating of “Sell”.

Zhengye Biotechnology Company Profile

Zhengye Biotechnology Holding Limited is a veterinary vaccine manufacturer which encompasses research, development, manufacturing and sales of veterinary vaccines, with a focus on livestock vaccine principally in China. Zhengye Biotechnology Holding Limited is based in Jilin, China.